Literature DB >> 13577820

The rearrangement of epinephrine.

J H FELLMAN.   

Abstract

Keywords:  EPINEPHRINE

Mesh：

Substances：

Year:  1958        PMID： 13577820     DOI： 10.1038/182311a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  Biochemical characterization of the catecholaldehyde reactivity of L-carnosine and its therapeutic potential in human myocardium.

Authors:  Margaret-Ann M Nelson; Zachariah J Builta; T Blake Monroe; Jonathan A Doorn; Ethan J Anderson
Journal:  Amino Acids       Date:  2018-09-06       Impact factor: 3.520

2.  Oxidation of 3,4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinone.

Authors:  David G Anderson; S V Santhana Mariappan; Garry R Buettner; Jonathan A Doorn
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

3.  Atropselective Oxidation of 2,2',3,3',4,6'-Hexachlorobiphenyl (PCB 132) to Hydroxylated Metabolites by Human Liver Microsomes and Its Implications for PCB 132 Neurotoxicity.

Authors:  Eric Uwimana; Brianna Cagle; Coby Yeung; Xueshu Li; Eric V Patterson; Jonathan A Doorn; Hans-Joachim Lehmler
Journal:  Toxicol Sci       Date:  2019-07-03       Impact factor: 4.849

4.  Antioxidant-Mediated Modulation of Protein Reactivity for 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite.

Authors:  David G Anderson; Virginia R Florang; Josephine H Schamp; Garry R Buettner; Jonathan A Doorn
Journal:  Chem Res Toxicol       Date:  2016-06-15       Impact factor: 3.739

5.  In vitro inhibition of glutathione-S-transferase by dopamine and its metabolites, 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylacetic acid.

Authors:  Rachel A Crawford; Kate R Bowman; Brianna S Cagle; Jonathan A Doorn
Journal:  Neurotoxicology       Date:  2021-07-24       Impact factor: 4.398
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.